WO2026069206 - HYPOIMMUNOGENIC MODIFIED GAMMA DELTA T CELLS
National phase entry is expected:
Publication Number
WO/2026/069206
Publication Date
02.04.2026
International Application No.
PCT/IB2025/059684
International Filing Date
25.09.2025
Title **
[English]
HYPOIMMUNOGENIC MODIFIED GAMMA DELTA T CELLS
[French]
LYMPHOCYTES T GAMMA DELTA MODIFIÉS HYPOIMMUNOGÈNES
Applicants **
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors
SHI, Xi
NG, Mei Rosa
MAI, Doanh
DONG, Xingyue
SHI, Yaoyao
ZHOU, Qingxuan
Priority Data
63/699,017
25.09.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3175 | |
| EPO | Filing, Examination, Granting | 24817 | |
| Japan | Filing, Examination, Granting | 3110 | |
| South Korea | Filing, Examination, Granting | 3905 | |
| USA | Filing, Examination, Granting | 13340 |
Total:
48,347
Contact Us
Abstract[English]
immunogenicity, and the use thereof.[French]
réduite, et leur utilisation.